Literature DB >> 18755194

A study on pathogenicity and mosquito transmission success in the rodent malaria parasite Plasmodium chabaudi adami.

Naomi Gadsby1, Richard Lawrence, Richard Carter.   

Abstract

We investigated the parasitology, pathogenicity (virulence) and infectivity to mosquitoes of blood infections in mice, of two strains, DS and DK, of the rodent malaria parasite Plasmodium chabaudi adami. Blood infections of DS were found to be highly pathogenic; the asexual parasites in these infections were fast-growing and showed no evidence of selectivity in their infection of host erythrocytes. In contrast to DS, blood infections of DK were much less pathogenic; the asexual parasites were slower-growing and showed a moderate degree of selectivity to a subset of erythrocytes which were not reticulocytes. In both DS and DK infections, infectivity to mosquitoes was highest before the peak of asexual parasitaemia had occurred; usually this did not coincide with the time when gametocyte numbers in the blood were highest. Infections with the pathogenic DS strain in CBA mice produced fewer gametocytes than did the less pathogenic DK strain. The DS strain infections in both CBA and C57 mice were also significantly much less infective to mosquitoes than the DK strain. Investigations by others on the related rodent malaria parasite subspecies, Plasmodium chabaudi chabaudi, have indicated that the mosquito infectivity of blood infections in mice tended to be higher in the more pathogenic (virulent) and lower in the less pathogenic strains of this parasite subspecies. This is the converse of the finding of the present investigation of blood infections of P. c. adami in mice in which a more pathogenic, or virulent, strain (DS) of these parasites was significantly much less infective to mosquitoes than was a less pathogenic strain (DK).

Entities:  

Mesh:

Year:  2008        PMID: 18755194     DOI: 10.1016/j.ijpara.2008.07.005

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  7 in total

Review 1.  The contribution of Plasmodium chabaudi to our understanding of malaria.

Authors:  Robin Stephens; Richard L Culleton; Tracey J Lamb
Journal:  Trends Parasitol       Date:  2011-11-17

2.  Protocol for production of a genetic cross of the rodent malaria parasites.

Authors:  Sittiporn Pattaradilokrat; Jian Li; Xin-zhuan Su
Journal:  J Vis Exp       Date:  2011-01-03       Impact factor: 1.355

3.  Optimized protocols for improving the likelihood of cloning recombinant progeny from Plasmodium yoelii genetic crosses.

Authors:  Yanwei Qi; Feng Zhu; Jian Li; Yong Fu; Sittiporn Pattaradilokrat; Linxian Hong; Shengfa Liu; Fusheng Huang; Wenyue Xu; Xin-Zhuan Su
Journal:  Exp Parasitol       Date:  2012-10-29       Impact factor: 2.011

Review 4.  Helminth parasites alter protection against Plasmodium infection.

Authors:  Víctor H Salazar-Castañon; Martha Legorreta-Herrera; Miriam Rodriguez-Sosa
Journal:  Biomed Res Int       Date:  2014-09-08       Impact factor: 3.411

5.  A comprehensive evaluation of rodent malaria parasite genomes and gene expression.

Authors:  Thomas D Otto; Ulrike Böhme; Andrew P Jackson; Martin Hunt; Blandine Franke-Fayard; Wieteke A M Hoeijmakers; Agnieszka A Religa; Lauren Robertson; Mandy Sanders; Solabomi A Ogun; Deirdre Cunningham; Annette Erhart; Oliver Billker; Shahid M Khan; Hendrik G Stunnenberg; Jean Langhorne; Anthony A Holder; Andrew P Waters; Chris I Newbold; Arnab Pain; Matthew Berriman; Chris J Janse
Journal:  BMC Biol       Date:  2014-10-30       Impact factor: 7.431

6.  New targets for drug discovery against malaria.

Authors:  Guido Santos; Néstor V Torres
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

7.  Preconditioning with hemin decreases Plasmodium chabaudi adami parasitemia and inhibits erythropoiesis in BALB/c mice.

Authors:  Esther Dalko; Véronique Gaudreault; Jaime Sanchez Dardon; Robert Moreau; Tatiana Scorza
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.